The Personalized Medicine World Conference (PMWC) 2011 is a two-day business and educational conference and is a follow-on to the sold-out PMWC 2010, held last January and the PMWC Israel this past June.

The PMWC promotes the accelerated adoption of Personalized Medicine on a global-scale, acting as the nexus between research, academia, investment, industry and the entrepreneurial spirit of Silicon Valley. The Conference includes sessions covering the latest advances in clinical practice, regulation and the economics of Personalized Medicine.

During the last year, several new and existing start-ups in the field have raised significant venture funds. Novel molecular diagnostics and targeted drugs are moving through the regulatory approval pipeline and promising new treatment options are becoming available. Personalized Medicine is revolutionizing health-care and transforming the traditional patient-physician relationship as patients are becoming empowered to actively participate in making clinical decisions.

PROGRAM
The Conference's Main Program incorporates four consecutive tracks in conjunction with parallel sessions. View program here.

Exhibition, Parallel Company Presentations and Company Award Competition will feature select companies recognized for their breakthrough products and services. In the final stage, Top 3 companies will present in front of an Award Panel and the audience, one of which will be chosen as the PMWC Israel Most Promising Company Award 2011.

The PMWC Israel Most Promising Company Winner: Applied Immune Technologies (AIT), a drug development company specializing in T-Cell Receptor-Like (TCRL) antibodies.